These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15081019)

  • 1. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; Balzarini J; De Clercq E; González-Muñiz R
    Bioorg Med Chem Lett; 2004 May; 14(9):2253-6. PubMed ID: 15081019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity.
    de Castro S; Lobatón E; Pérez-Pérez MJ; San-Félix A; Cordeiro A; Andrei G; Snoeck R; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2005 Feb; 48(4):1158-68. PubMed ID: 15715482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors.
    Pérez-Faginas P; Aranda MT; García-López MT; Snoeck R; Andrei G; Balzarini J; González-Muñiz R
    Bioorg Med Chem; 2011 Feb; 19(3):1155-61. PubMed ID: 21256035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.
    Borthwick AD; Crame AJ; Ertl PF; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Singh OM; Weingarten GG; Woolven JM
    J Med Chem; 2002 Jan; 45(1):1-18. PubMed ID: 11754575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidomimetic inhibitors of the human cytomegalovirus protease.
    Ogilvie W; Bailey M; Poupart MA; Abraham A; Bhavsar A; Bonneau P; Bordeleau J; Bousquet Y; Chabot C; Duceppe JS; Fazal G; Goulet S; Grand-Maître C; Guse I; Halmos T; Lavallée P; Leach M; Malenfant E; O'Meara J; Plante R; Plouffe C; Poirier M; Soucy F; Yoakim C; Déziel R
    J Med Chem; 1997 Dec; 40(25):4113-35. PubMed ID: 9406601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and antiviral evaluation of purine-β-lactam and purine-aminopropanol hybrids.
    D'hooghe M; Mollet K; De Vreese R; Jonckers TH; Dams G; De Kimpe N
    J Med Chem; 2012 Jun; 55(11):5637-41. PubMed ID: 22519297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of berberine and related compounds against human cytomegalovirus.
    Hayashi K; Minoda K; Nagaoka Y; Hayashi T; Uesato S
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1562-4. PubMed ID: 17239594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of elastase by N-sulfonylaryl beta-lactams: anatomy of a stable acyl-enzyme complex.
    Wilmouth RC; Westwood NJ; Anderson K; Brownlee W; Claridge TD; Clifton IJ; Pritchard GJ; Aplin RT; Schofield CJ
    Biochemistry; 1998 Dec; 37(50):17506-13. PubMed ID: 9860865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
    Michaelis M; Ha TA; Doerr HW; Cinatl J
    Cardiovasc Res; 2008 Feb; 77(3):544-50. PubMed ID: 18006438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors.
    Falardeau G; Lachance H; St-Pierre A; Yannopoulos CG; Drouin M; Bédard J; Chan L
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1693-5. PubMed ID: 15745823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel series of inhibitors of human cytomegalovirus primase.
    Cushing TD; Adrian J; Chen X; DiMaio H; Doughan B; Flygare J; Liang L; Mayorga V; Miao S; Mellon H; Peterson MG; Powers JP; Spector F; Stein C; Wright M; Xu D; Ye Q; Jaen J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4879-83. PubMed ID: 16814545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and antiviral activity of certain 3-substituted 2,5,6-trichloroindole nucleosides.
    Williams JD; Chen JJ; Drach JC; Townsend LB
    J Med Chem; 2004 Nov; 47(23):5753-65. PubMed ID: 15509174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].
    Gunda T
    Acta Pharm Hung; 2002; 72(4):223-30. PubMed ID: 12812042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and enzymatic evaluation of N1-acyloxyalkyl- and N1-oxazolidin-2,4-dion-5-yl-substituted beta-lactams as novel inhibitors of human leukocyte elastase.
    Moreira R; Santana AB; Iley J; Neres J; Douglas KT; Horton PN; Hursthouse MB
    J Med Chem; 2005 Jul; 48(15):4861-70. PubMed ID: 16033266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiviral activity of 3-formyl- and 3-cyano-2,5,6-trichloroindole nucleoside derivatives.
    Williams JD; Chen JJ; Drach JC; Townsend LB
    J Med Chem; 2004 Nov; 47(23):5766-72. PubMed ID: 15509175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.